JP2019523283A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019523283A5 JP2019523283A5 JP2019505171A JP2019505171A JP2019523283A5 JP 2019523283 A5 JP2019523283 A5 JP 2019523283A5 JP 2019505171 A JP2019505171 A JP 2019505171A JP 2019505171 A JP2019505171 A JP 2019505171A JP 2019523283 A5 JP2019523283 A5 JP 2019523283A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- amount
- weight
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 241000218236 Cannabis Species 0.000 claims 7
- 150000003505 terpenes Chemical class 0.000 claims 5
- 235000007586 terpenes Nutrition 0.000 claims 5
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims 4
- TWKHUZXSTKISQC-UHFFFAOYSA-N 2-(5-methyl-2-prop-1-en-2-ylphenyl)-5-pentylbenzene-1,3-diol Chemical compound OC1=CC(CCCCC)=CC(O)=C1C1=CC(C)=CC=C1C(C)=C TWKHUZXSTKISQC-UHFFFAOYSA-N 0.000 claims 3
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 3
- 208000019116 sleep disease Diseases 0.000 claims 3
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 2
- 229950011318 cannabidiol Drugs 0.000 claims 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 2
- 229960004242 dronabinol Drugs 0.000 claims 2
- 235000001510 limonene Nutrition 0.000 claims 2
- 229940087305 limonene Drugs 0.000 claims 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims 2
- 208000020685 sleep-wake disease Diseases 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 claims 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 claims 2
- FQTLCLSUCSAZDY-UHFFFAOYSA-N (+) E(S) nerolidol Natural products CC(C)=CCCC(C)=CCCC(C)(O)C=C FQTLCLSUCSAZDY-UHFFFAOYSA-N 0.000 claims 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 claims 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 claims 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 claims 1
- FQTLCLSUCSAZDY-ATGUSINASA-N Nerolidol Chemical compound CC(C)=CCC\C(C)=C\CC[C@](C)(O)C=C FQTLCLSUCSAZDY-ATGUSINASA-N 0.000 claims 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 claims 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 claims 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 claims 1
- 229930006722 beta-pinene Natural products 0.000 claims 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 claims 1
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 claims 1
- 239000010460 hemp oil Substances 0.000 claims 1
- 229930007744 linalool Natural products 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 claims 1
- 150000007823 ocimene derivatives Chemical class 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662370304P | 2016-08-03 | 2016-08-03 | |
| US62/370,304 | 2016-08-03 | ||
| PCT/AU2017/050814 WO2018023163A1 (en) | 2016-08-03 | 2017-08-03 | Cannabis composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019523283A JP2019523283A (ja) | 2019-08-22 |
| JP2019523283A5 true JP2019523283A5 (https=) | 2020-01-23 |
Family
ID=61072172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019505171A Pending JP2019523283A (ja) | 2016-08-03 | 2017-08-03 | 大麻組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11779562B2 (https=) |
| EP (1) | EP3493798A4 (https=) |
| JP (1) | JP2019523283A (https=) |
| KR (2) | KR20190035791A (https=) |
| CN (1) | CN109843287A (https=) |
| AU (4) | AU2017307643B2 (https=) |
| BR (1) | BR112019001852A2 (https=) |
| CA (1) | CA3031810A1 (https=) |
| CL (1) | CL2019000270A1 (https=) |
| CO (1) | CO2019001044A2 (https=) |
| IL (2) | IL264461B2 (https=) |
| MX (1) | MX386620B (https=) |
| PE (1) | PE20200726A1 (https=) |
| SG (1) | SG11201900665VA (https=) |
| WO (1) | WO2018023163A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018023166A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| SG11201900665VA (en) | 2016-08-03 | 2019-02-27 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| NZ757591A (en) * | 2017-03-30 | 2026-03-27 | Ojai Energetics Pbc | Methods and compositions for enhancing health |
| BR112019026877A2 (pt) | 2017-06-19 | 2020-06-30 | Zelda Therapeutics Operations Pty Ltd | composições para distúrbios do sono e tratamentos do mesmo |
| CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
| WO2019173242A1 (en) * | 2018-03-04 | 2019-09-12 | Cmg Partners, Inc. | Enhanced smokable cannabis-based therapeutic product for treatment of sleep disorders and chronic pain and method for making same |
| CA3103938A1 (en) * | 2018-06-15 | 2019-12-19 | California Cannabinoids | Compositions and methods for treatment of narcolepsy and related disorders |
| WO2020077153A1 (en) | 2018-10-10 | 2020-04-16 | Canopy Holdings, LLC | Synthesis of cannabigerol |
| WO2020168073A1 (en) * | 2019-02-13 | 2020-08-20 | Caras Jim | Composition comprising hydrolyzed collagen and cannabidiol and use thereof |
| NL2022616B1 (en) | 2019-02-21 | 2020-09-18 | Patrick Alexander Unger | Cannabigerol and pharmaceutical compositions comprising cannabigerol for use in the treatment of insomnia |
| US11554098B2 (en) | 2019-05-03 | 2023-01-17 | HFL Partners, LLC | Compositions comprising molecularly separated cannabinoids and terpene blends and methods of producing |
| CN118161552A (zh) * | 2019-12-19 | 2024-06-11 | 史蒂文·罗斯斯坦 | 富含多酚化合物的提取物以及相关方法 |
| US11000818B1 (en) * | 2019-12-27 | 2021-05-11 | Cresco Labs Llc | Post processing method for cannabis oil |
| IT202000017137A1 (it) * | 2020-07-15 | 2022-01-15 | Linnea Sa | Estratti di cannabis sativa e loro usi |
| DK181329B1 (en) * | 2021-05-04 | 2023-08-16 | Cs Medica As | Nasal sleep spray composition, method for its provision, and receptacle and kit comprising said composition |
| US20230000935A1 (en) * | 2021-07-03 | 2023-01-05 | Joseph Anthony Bidwell | Extract Infused Cannabis Flower, Natural preservation of Cannabis Flower and the method therefor |
| US20250144122A1 (en) * | 2023-11-06 | 2025-05-08 | Roberto Colon-Cruz | Scent-Changing Ointment & Method of Making The Same |
| KR20260005072A (ko) * | 2024-07-01 | 2026-01-09 | 피비엘바이오랩 주식회사 | 신규 유산균 및 이의 용도 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2400320B (en) | 2001-05-04 | 2005-06-08 | Gw Pharma Ltd | Cannabinoid-rich extracts |
| JP4411117B2 (ja) * | 2004-03-25 | 2010-02-10 | エスエス製薬株式会社 | 睡眠改善医薬組成物 |
| GB2418612A (en) | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
| JP2007246428A (ja) * | 2006-03-15 | 2007-09-27 | Nature Technology Inc | 植物精油成分を有効成分とする経皮吸収型睡眠覚醒用医薬組成物、その組成物を含有する経皮吸収型睡眠覚醒用医薬製剤、及びこれらの製造方法 |
| GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| KR20110120153A (ko) * | 2010-04-28 | 2011-11-03 | 고려대학교 산학협력단 | 리모넨을 함유하는 아데노신 Ａ2ａ 수용체 작용제 |
| GB2514054A (en) | 2011-09-29 | 2014-11-12 | Gw Pharma Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| GB2496688B (en) | 2011-11-21 | 2016-06-29 | Gw Pharma Ltd | Tetrahydrocannabivarin for use in the treatment of intestinal inflammatory diseases |
| WO2013165251A1 (en) | 2012-05-03 | 2013-11-07 | Echo Pharmaceuticals B.V. | Cannabis plant isolate comprising /\9-tetrahydrocannabinol and a method for preparing such an isolate |
| CA2895805A1 (en) | 2012-12-18 | 2014-06-26 | Kotzker Consulting Llc | Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity |
| EP2968259B1 (en) | 2013-03-14 | 2022-09-14 | SC Laboratories Inc. | Bioactive concentrates and uses thereof |
| WO2014145490A2 (en) * | 2013-03-15 | 2014-09-18 | Biotech Institute, Llc | Breeding, production, processing and use of specialty cannabis |
| US10265292B2 (en) | 2013-09-18 | 2019-04-23 | The Werc Shop, LLC | Terpene-based compositions, processes methodologies |
| HRP20221172T1 (hr) * | 2013-10-29 | 2023-02-03 | Biotech Institute, Llc | Uzgoj, proizvodnja, prerada i uporaba specijalnog sinsemilla kanabisa |
| WO2015068052A2 (en) | 2013-10-31 | 2015-05-14 | Full Spectrum Laboratories, Ltd. | Terpene and cannabinoid formulations |
| EP3160445B1 (en) * | 2014-06-26 | 2021-10-20 | Island Breeze Systems Ca, LLC | Mdi related products and methods of use |
| AU2015279612A1 (en) | 2014-06-27 | 2017-02-02 | Kenton L. Crowley | Buccal and sublingual cannabinoid formulations and method of making the same |
| AU2015308546A1 (en) * | 2014-08-25 | 2017-04-13 | Clk Consult V/ Carsten Leonhard Knudsen | Device with compositions for delivery to the lungs, the oral mucosa and the brain |
| BR122021018502B1 (pt) * | 2014-10-21 | 2022-05-03 | United Cannabis Corp | Formulação de canabinoide líquida |
| MX395015B (es) | 2014-12-12 | 2025-03-24 | Ojai Energetics Pbc | Composiciones microencapsuladas de cannabinoides |
| CA2974292C (en) | 2015-01-31 | 2024-04-16 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
| AU2016225026A1 (en) | 2015-02-27 | 2017-09-07 | Canopy Growth Corporation | Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral |
| SG11201900665VA (en) | 2016-08-03 | 2019-02-27 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| JP2019523282A (ja) | 2016-08-03 | 2019-08-22 | ゼルダ セラピューティクス オペレーションズ ピーティーワイ リミテッド | 大麻組成物 |
| WO2018023166A1 (en) | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
| BR112019026877A2 (pt) | 2017-06-19 | 2020-06-30 | Zelda Therapeutics Operations Pty Ltd | composições para distúrbios do sono e tratamentos do mesmo |
| AU2018101357B4 (en) | 2017-09-15 | 2022-03-17 | Zelira Therapeutics Operations Pty Ltd | Composition and method for treating autism |
| AU2018100924A4 (en) | 2018-07-03 | 2018-08-09 | Zelira Therapeutics Operations Pty Ltd | Composition and method for treating pain |
| MX2022015799A (es) | 2020-06-12 | 2023-04-11 | Zelira Therapeutics Operations Pty Ltd | Composicion y metodo para el tratamiento del dolor cronico. |
| AU2021376539A1 (en) | 2020-11-06 | 2023-06-15 | Zelira Therapeutics Operations Pty Ltd | Cannabinoid encapsulation technology |
-
2017
- 2017-08-03 SG SG11201900665VA patent/SG11201900665VA/en unknown
- 2017-08-03 BR BR112019001852-2A patent/BR112019001852A2/pt not_active Application Discontinuation
- 2017-08-03 CN CN201780060688.4A patent/CN109843287A/zh active Pending
- 2017-08-03 CA CA3031810A patent/CA3031810A1/en active Pending
- 2017-08-03 KR KR1020197005589A patent/KR20190035791A/ko not_active Ceased
- 2017-08-03 AU AU2017307643A patent/AU2017307643B2/en not_active Ceased
- 2017-08-03 KR KR1020217002290A patent/KR20210013645A/ko not_active Ceased
- 2017-08-03 EP EP17836097.0A patent/EP3493798A4/en active Pending
- 2017-08-03 WO PCT/AU2017/050814 patent/WO2018023163A1/en not_active Ceased
- 2017-08-03 PE PE2019000330A patent/PE20200726A1/es unknown
- 2017-08-03 MX MX2019001285A patent/MX386620B/es unknown
- 2017-08-03 JP JP2019505171A patent/JP2019523283A/ja active Pending
- 2017-08-03 IL IL264461A patent/IL264461B2/en unknown
- 2017-08-03 IL IL296008A patent/IL296008B2/en unknown
-
2018
- 2018-07-03 AU AU2018100923A patent/AU2018100923C4/en not_active Expired
-
2019
- 2019-01-31 CL CL2019000270A patent/CL2019000270A1/es unknown
- 2019-02-01 CO CONC2019/0001044A patent/CO2019001044A2/es unknown
- 2019-10-23 AU AU2019253841A patent/AU2019253841B2/en not_active Ceased
-
2021
- 2021-10-01 AU AU2021240297A patent/AU2021240297B2/en not_active Ceased
-
2022
- 2022-07-14 US US17/865,024 patent/US11779562B2/en active Active
-
2023
- 2023-09-01 US US18/460,012 patent/US12239628B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019523283A5 (https=) | ||
| JP2020524151A5 (https=) | ||
| MX387442B (es) | Composiciones y tratamientos para el trastorno del sueño | |
| JP2019526541A5 (https=) | ||
| MX386620B (es) | Composicion de cannabis | |
| Alvarez-Trabado et al. | Designing lipid nanoparticles for topical ocular drug delivery | |
| MX382192B (es) | Composiciones de canabinoide y usos. | |
| PE20200677A1 (es) | Composicion de cannabis | |
| JP2012532093A5 (https=) | ||
| JP2018530517A5 (https=) | ||
| UY35624A (es) | Uso de dosis elevadas de pridopidina para tratar la enfermedad de huntington | |
| EP4640275A3 (en) | USE OF CANNABIDIOL IN THE TREATMENT OF ANGELMAN SYNDROME ANXIETY | |
| NZ731248A (en) | Cannabis extracts and methods of preparing and using same | |
| BR112018075073A2 (pt) | composições nasais de canabidiol | |
| JP2007106777A5 (https=) | ||
| GB2492487A8 (en) | Cannabinoids for use in the treatment of neurodegenerative diseases or disorders | |
| CL2016002132A1 (es) | Uso de una cantidad de laquinimod, que sirve para preparar un medicamento para tratar un paciente humano afectado con esclerosis múltiple o que presenta un síndrome clínicamente aislado; un paquete, una cantidad de laquinimod y una composición farmacéutica del mismo. | |
| JP2016539125A5 (https=) | ||
| CL2016002276A1 (es) | Composiciones tópicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad | |
| JP2016538288A5 (https=) | ||
| MX2016008027A (es) | Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington. | |
| MX2018002298A (es) | Metodos de uso de interleucina 10 para el tratamiento de enfermedades y trastornos. | |
| NZ724678A (en) | New use of n,n-bis-2-mercaptoethyl isophthalamide | |
| Chatziralli | Various toxicities: 6 case reports | |
| Coates et al. | C63 LUNG INJURY AND REPAIR: TWO TO TANGO: Effect Of Caspase-1 Inhibition On Juvenile Influenza A Infection |